5 Reasons It's Not Too Late to Buy Eli Lilly Stock
Eli Lilly (NYSE: LLY) has been around for almost 150 years, finding ways to innovate and grow. Today, it's the most valuable ...
Compound versions of some weight loss drugs to be restricted
Zepbound contains the same active ingredient, tirzepatide, as Mounjaro, which is also made by Lilly and is FDA-approved to ...
STAT11d
Eli Lilly’s Dave Ricks takes home $114 million as obesity drugs fuel company’s fortunes
Eli Lilly’s rising fortunes tied to its weight loss and diabetes drugs led to a nine-figure payday for its top executive.
The Print on MSN3d
Fat-busting drug Mounjaro launched in India. Here’s how much it will cost
US pharma giant Eli Lilly's Mounjaro can prove crucial in treatment of obesity & type 2 diabetes. Launched in the US in 2022, ...
The Financial Express2d
Eli Lilly’s popular anti-obesity drug debuts in India
Dr Reddy’s Laboratories is also working on a generic version of Wegovy. (Image/Getty) US pharma major Eli Lilly on Thursday launched its global bestseller anti-obesity and diabetes drug Mounjaro ...
Health News Florida3d
Patients scramble as cheaper obesity drug alternatives disappear
Compounding pharmacies have been allowed to essentially make a cheaper version of Eli Lilly's Zepbound, but they have to stop ...
Eli Lilly launches weight loss drug in India beating Novo Nordisk
Eli Lilly (LLY) stock in focus as the company launches its weight loss therapy Mounjaro in India, beating its rival Novo Nordisk (NVO). Read more here.
AOL11d
Compound versions of some weight loss drugs to be restricted
or in circumstances when a patient can't take a version of a drug made by a pharmaceutical company and they need an alternative. In recent months, Eli Lilly, the maker of Zepbound and Mounjaro ...